Every claim we hold, and how far we can stand behind it.
142 claims across 39 products. 28% are confirmed against the source text by the evidence gate; 39% come from a class with no vendor interest. Everything below is browsable, filterable, and available as JSON.
| Evidence class | Claims | Confirmed | What it can support |
|---|---|---|---|
| Peer-reviewed study | 19 | 5 | Reviewed before publication; assess study quality, funding, conflicts, and relevance to your setting. |
| Regulatory filing | 4 | 0 | A statement made to a regulator, where being wrong has consequences. |
| Independent report | 32 | 9 | Reporting outside a vendor publication; assess underlying data, sponsorship, and conflicts separately. |
| Customer case | 4 | 3 | A real deployment, but selected and framed by someone with an interest. |
| Press release | 63 | 22 | The vendor's own announcement. Useful for dates and facts, not for outcomes. |
| Vendor page | 20 | 1 | Marketing copy. Establishes what is claimed, never that it is true. |
Showing 3 of 3 matching claims (142 in the full corpus) · 0% of this selection is confirmed · clear filters
Completed a $65M Series D led by Lightspeed and 360 ONE Asset (Sept 2024); solutions deployed in 90+ countries across 3,000+ sites
Provenance
- Claim ID
- clm_9db738bc406a8512a625
- Version
- 1
- Workflow
- Imaging & Diagnostic AI
- Dimension
- market durability
- Retrieved
- 2026-08-27
- Reviewer
- healthit-gate-v1
- Source URL
- https://www.globenewswire.com/news-release/2024/09/25/2953204/0/en/Global-healthcare-AI-innovator-Qure-ai-completes-65-million-Series-D-funding-round-led-by-Lightspeed-and-360One-Asset.html
CERTAIN study (European Heart Journal - Cardiovascular Imaging, 2024): in 750 consecutive patients at 5 expert CCTA sites, Cleerly AI-QCT analysis improved physicians' confidence two- to five-fold at every step of the care pathway, changed diagnosis or management in 57.1% (428) of patients (P<0.001), and reduced the need for downstream non-invasive and invasive testing by 37.1% (P<0.001) versus conventional visual CCTA interpretation.
Provenance
- Claim ID
- clm_a7d0185737df3457a3b3
- Version
- 1
- Workflow
- Imaging & Diagnostic AI
- Dimension
- evidence strength
- Retrieved
- 2026-08-27
- Reviewer
- healthit-gate-v1
- Source URL
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11139521/
Completed SOC 2 Type II and HIPAA audits for the Viz.ai One Platform, marking the fourth consecutive year of SOC 2 Type II compliance
Provenance
- Claim ID
- clm_475a430afcb48493c9c8
- Version
- 1
- Workflow
- Imaging & Diagnostic AI
- Dimension
- trust governance
- Retrieved
- 2026-08-27
- Reviewer
- healthit-gate-v1
- Source URL
- https://www.viz.ai/news/viz-ai-announces-successful-completion-of-soc-2-type-ii-hipaa-audits-for-viz-ai-one-platform